Search Count: 6
 |
Hiv-1 Wild Type Protease With Grl-110-19A, A Chloroacetamide Derivative Based On Darunavir As P2' Group
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.29 Å Release Date: 2023-02-15 Classification: HYDROLASE/INHIBITOR |
 |
Hiv-1 Wild Type Protease With Grl-05816A, With C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2-Ligand [Diastereomer 1]
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.13 Å Release Date: 2022-03-02 Classification: ANTIVIRAL PROTEIN/INHIBITOR |
 |
Hiv-1 Wild Type Protease With Grl-01717A, With C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2-Ligand [Diastereomer 2]
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.21 Å Release Date: 2022-03-02 Classification: VIRAL PROTEIN/INHIBITOR |
 |
X-Ray Structure Of Sars-Cov-2 Main Protease Covalently Modified By Compound Grl-017-20
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-09-29 Classification: VIRAL PROTEIN Ligands: 4IJ |
 |
X-Ray Structure Of Sars-Cov-2 Main Protease Covalently Modified By Compound Grl-091-20
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-09-29 Classification: VIRAL PROTEIN Ligands: 4I9, NA |
 |
X-Ray Structure Of Sars-Cov Main Protease Covalently Modified By Compound Grl-0686
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2021-09-29 Classification: VIRAL PROTEIN Ligands: 4IO, DMS |